Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Infinity Pharmaceuticals Inc (NASDAQ:INFI)

1.92
Delayed Data
As of Apr 21
 -0.05 / -2.54%
Today’s Change
0.84
Today|||52-Week Range
6.63
+42.22%
Year-to-Date
AbbVie (ABBV) Presents Positive Data on HCV Combination Drug
Apr 21 / Zacks.com - Paid Partner Content
Should You Retain Universal Health (UHS) Stock in Portfolio?
Apr 12 / Zacks.com - Paid Partner Content
Nivalis' (NVLS) Shares Down After Merger Deal with Alpine
Apr 20 / Zacks.com - Paid Partner Content
Here's Why You Should Dump Tenet Healthcare (THC) Stock Now
Apr 10 / Zacks.com - Paid Partner Content
Ultragenyx's Hypophosphatemia Drug Succeeds in Phase III
Apr 19 / Zacks.com - Paid Partner Content
Infinity Pharmaceuticals Focuses on Lead Candidate IPI-549
Apr 10 / Zacks.com - Paid Partner Content
Why Is Infinity (INFI) Down 37.4% Since the Last Earnings Report?
Apr 19 / Zacks.com - Paid Partner Content
Ultragenyx's (RARE) XLH Drug Positive in Phase II Study
Apr 10 / Zacks.com - Paid Partner Content
AMAG Files for FDA Approval of Subcutaneous Form of Makena
Apr 18 / Zacks.com - Paid Partner Content
Cardiome Pharma (CRME) Jumps: Stock Adds 6.6% in Session
Apr 10 / Zacks.com - Paid Partner Content
Infinity Pharmaceuticals (INFI) Looks Good: Stock Jumps 19%
Apr 18 / Zacks.com - Paid Partner Content
New Strong Buy Stocks for April 10th
Apr 10 / Zacks.com - Paid Partner Content
Bio-Path Holdings (BPTH) Looks Good: Stock Moves 13% Higher
Apr 17 / Zacks.com - Paid Partner Content